Concepedia
Statistics
Publications
22
Citations
5.8K
H-Index
16
Active since
2006
Affiliations
Institut Gustave Roussy(Current)
The University of Texas MD Anderson Cancer Center
Merck & Co., Inc., Rahway, NJ, USA (United States)
National Cancer Center
Dana-Farber Cancer Institute
Jaime Mejia is an author at Institut Gustave Roussy specializing in medicine, oncology, and chemotherapy.
Publications per year
2006–2024
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2008 · 2.9K citations · Full text
Medicine, Oncology, Breast Oncology +16
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer
Kenneth R. Hess, K. Anderson, W. Fraser Symmans et al. · Journal of Clinical Oncology · 2006 · 728 citations
Medicine, Oncology, Pharmacology +13
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Eric P. Winer, Oleg Lipatov, Seock‐Ah Im et al. · The Lancet Oncology · 2021 · 493 citations
Medicine, Oncology, Pharmacology +14
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos et al. · The Lancet Oncology · 2019 · 477 citations
Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2023 · 351 citations
1–5 of 22